DISCOUNT ZERTIFIKAT - EDWARDS LIFESCIENCES | Market Closed - Börse Stuttgart 01:05:23 21/06/2024 pm IST | ||
| 73.37 EUR | +0.63% |
|
| Current month | +0.96% | ||
| 1 month | +0.88% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 21/24/21 | 73.37 | +0.63% |
| 20/24/20 | 72.91 | +0.18% |
| 19/24/19 | 72.78 | +0.78% |
| 18/24/18 | 72.22 | -0.65% |
| 17/24/17 | 72.69 | -0.11% |
Delayed Quote Börse Stuttgart
Last update June 21, 2024 at 01:05 pm IST
More quotesStatic data
| Product type | Certificati Discount |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
BNP Paribas
|
| WKN | PC56P9 |
| ISIN | DE000PC56P96 |
| Date issued | 04/03/2024 |
| Maturity | 19/12/2025 (544 Days) |
| Parity | 1 : 1 |
| Emission price | 69.56 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 74.27 € |
|---|---|
| Lowest since issue | 69.73 € |
| Spread | 0.1 € |
| Spread % | 0.13% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
90.9
USD
Average target price
96.05
USD
Spread / Average Target
+5.67%
- Stock Market
- Certificates
- Certificat
